Schedule 13D ownership disclosure

NRX PHARMACEUTICALS INC

Security class unavailable · CUSIP: 629444100

Event date: 2021-05-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
60.6600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950142-21-001848
Form type
SC 13D
Filer
Javitt Jonathan C
CIK
CIK 1303782
Filed
Jun 03, 2021
Reporting period
May 24, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub